Streptococcus gallolyticus infection in colorectal cancer leand association with biological and clinical factors


Por: Andres-Franch M, Galiana A, Sanchez-Hellin V, Ochoa E, Hernandez-Illan E, Lopez-Garcia P, Castillejo A, Castillejo M, Barbera V, Garcia-Dura J, Gomez-Romero F, Royo G, Soto J

Publicada: 29 mar 2017
Resumen:
There is an unambiguous association of Streptococcus gallolyticus infection with colorectal cancer, although there is limited information about epidemiology or interaction between molecular and environmental factors. We performed an original quantitative analysis of S. gallolyticus in unselected colorectal cancer patients (n = 190) and their association with clinical, pathological tumor molecular profiles (microsatellite instability, hypermethylator phenotype and chromosomal instability pathways), and other biological factors in colorectal tumor and normal tissues (cytomegalovirus and Epstein-Barr virus infection). We developed a new quantitative method to assess bacterial load. Analytical validation was reached with a very high sensitivity and specificity. Our results showed a 3.2% prevalence of S. gallolyticus infection in our unselected cohort of colorectal cancer cases (6/190). The average S. gallolyticus copy number was 7,018 (range 44-34,585). No previous reports relating to S. gallolyticus infection have been published for unselected cohorts of patients. Finally, and despite a low prevalence of S. gallolyticus in this study, we were able to define a specific association with tumor tissue (p = 0.03) and with coinfection with Epstein-Barr virus (p = 0.042; OR: 9.49; 95% IC: 1.1-82.9). The prevalence data provided will be very useful in the design of future studies, and will make it possible to estimate the sample size needed to assess precise objectives. In conclusion, our results show a low prevalence of S. gallolyticus infection in unselected colorectal cancer patients and an association of positive S. gallolyticus infection with tumor tissue and Epstein-Barr virus coinfection. Further studies will be needed to definitively assess the prevalence of S. gallolyticus in colorectal cancer and the associated clinicopathological and molecular profiles.

Filiaciones:
Andres-Franch M:
 Hosp Gen Univ Elche, Dept Microbiol, Elche, Spain

Galiana A:
 Hosp Gen Univ Elche, Dept Microbiol, Elche, Spain

Sanchez-Hellin V:
 Hosp Gen Univ Elche, Dept Microbiol, Elche, Spain

Ochoa E:
 Hosp Prov Castellon, Biopathol Dept, Castellon de La Plana, Spain

Hernandez-Illan E:
 Hosp Gen Univ Alicante, Res Lab, Alicante, Spain

 Inst Invest Sanitaria & Biomed Alicante ISABIAL F, Alicante, Spain

Lopez-Garcia P:
 Hosp Gen Univ Elche, Dept Microbiol, Elche, Spain

Castillejo A:
 Inst Invest Sanitaria & Biomed Alicante ISABIAL F, Alicante, Spain

 Hosp Gen Univ Elche, Mol Genet Unit, Elche, Spain

Castillejo M:
 Inst Invest Sanitaria & Biomed Alicante ISABIAL F, Alicante, Spain

 Hosp Gen Univ Elche, Mol Genet Unit, Elche, Spain

Barbera V:
 Inst Invest Sanitaria & Biomed Alicante ISABIAL F, Alicante, Spain

 Hosp Gen Univ Elche, Mol Genet Unit, Elche, Spain

Garcia-Dura J:
 Hosp Gen Univ Elche, Dept Microbiol, Elche, Spain

Gomez-Romero F:
 Hosp Gen Univ Elche, Dept Prevent Med, Elche, Spain

Royo G:
 Hosp Gen Univ Elche, Dept Microbiol, Elche, Spain

Soto J:
 Inst Invest Sanitaria & Biomed Alicante ISABIAL F, Alicante, Spain

 Hosp Gen Univ Elche, Mol Genet Unit, Elche, Spain
ISSN: 19326203





Plos One
Editorial
PUBLIC LIBRARY SCIENCE, 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 12 Número: 3
Páginas:
WOS Id: 000399174600042
ID de PubMed: 28355283

MÉTRICAS